about
Role of T cells in type 2 diabetic nephropathymicroRNA in the development of diabetic complications.C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.Recent Advances of Curcumin in the Prevention and Treatment of Renal Fibrosis.Targeting JNK by a new curcumin analog to inhibit NF-kB-mediated expression of cell adhesion molecules attenuates renal macrophage infiltration and injury in diabetic mice.Macrophage polarization in kidney diseases.Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus.Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy.Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats.Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic ratsAstragalus membranaceus inhibits inflammation via phospho-P38 mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κB pathways in advanced glycation end product-stimulated macrophages.Naringin Alleviates Diabetic Kidney Disease through Inhibiting Oxidative Stress and Inflammatory ReactionAlterations in monocyte CD16 in association with diabetes complications.A glimpse of various pathogenetic mechanisms of diabetic nephropathy.The heme oxygenase system suppresses perirenal visceral adiposity, abates renal inflammation and ameliorates diabetic nephropathy in Zucker diabetic fatty rats.Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy.Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications.Weight loss interventions and progression of diabetic kidney disease.Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease.Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.Heparanase is essential for the development of diabetic nephropathy in mice.Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?Inhibition of 12/15-Lipoxygenase Reduces Renal Inflammation and Injury in Streptozotocin-Induced Diabetic Mice.Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy.Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
P2860
Q26849691-762FC956-4735-4780-AFA9-3A0E3F55B1C7Q30353835-A95182D8-D6C6-4023-AEEC-27A9C77FC529Q33620560-F929E77C-0F50-4471-A551-3F7A1BCC3374Q33701346-5C238E9D-F450-4F55-9B71-2B924FDA1BA4Q35048212-EE95413D-7EF8-4DA9-B90A-7C8B902F3E9EQ35737886-197E2D2B-9581-456B-AE89-4CC37FD7A6C8Q35763771-2D55D2E6-FE5B-4EBB-8C63-D9B77952C4F4Q35804146-6BA1327A-D715-42E9-A64E-0C68416FD4B8Q35924532-A141B724-B4FE-492E-B663-22B6F7F8D911Q36159004-00B475A0-CFF4-436D-8415-1FEFFB3FD533Q36197219-09ED8D8B-5A6A-46E8-9626-C30A858F73ABQ36331862-3E29AF42-404C-47E7-8400-139D48F6E52AQ36506979-29A7E9FD-A68A-4109-B2A8-AD44F833325CQ36979205-5F3C1251-A9A8-4AE4-881D-53157E7B2320Q37534705-06E7408A-BF53-4AB7-9CC4-4DB700985CB5Q37819453-C0124139-9127-4297-8E25-D512B1E27A45Q38054089-DDB2B996-4866-40E5-AAB6-B9796EBF1FB0Q38539937-870CF79A-98F8-463C-A0A5-807CC0F07A2EQ38756737-17CD23C4-1D23-4D7B-BF0D-39DCCF2092CCQ38985052-AB3B0D31-C753-4129-809C-7B7DFDE5473BQ39782778-5B6A7138-774B-4899-8D93-1ED16E4230D0Q41932191-A3E5720E-0FBB-48EA-AC7F-71ED6584033DQ42228384-D129925A-CB62-4C9C-8456-012EC7AC628EQ42371220-1513B5CD-C1D6-48BC-8B25-D84BED3D9A9FQ54351699-2882BFC9-85DC-4066-BC6B-02E999AAFCA2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Macrophages and diabetic nephropathy.
@en
Macrophages and diabetic nephropathy.
@nl
type
label
Macrophages and diabetic nephropathy.
@en
Macrophages and diabetic nephropathy.
@nl
prefLabel
Macrophages and diabetic nephropathy.
@en
Macrophages and diabetic nephropathy.
@nl
P1476
Macrophages and diabetic nephropathy.
@en
P2093
Greg H Tesch
P304
P356
10.1016/J.SEMNEPHROL.2010.03.007
P577
2010-05-01T00:00:00Z